Overview
Francis Coyne is a Hematologist Oncology specialist and a Pediatrics provider in Rochester, New York. Dr. Coyne is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobinopathy, and Hemoglobin E Disease.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
905 Culver Rd, Rochester, NY 14609
601 Elmwood Ave, Box 684, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Rochester
Steven Scofield is a Pediatrics specialist and a Pulmonary Medicine provider in Rochester, New York. Dr. Scofield is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Jaundice.
Tiffany Pulcino is a Hospital Medicine specialist and a Pediatrics provider in Rochester, New York. Dr. Pulcino is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Wolf-Hirschhorn Syndrome, Chronic Graft Versus Host Disease (cGvHD), Secondary Immunodeficiency (SID), and Discoid Lupus Erythematosus (DLE).
Mary M. Gooley Hemophilia Center Inc
Saad Jamshed is a Hematologist Oncology specialist and a Hematologist in Rochester, New York. Dr. Jamshed is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Angiosarcoma, Breast Cancer, Paget Disease of the Breast, and Acute Myeloid Leukemia (AML).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hemoglobin C DiseaseDr. Coyne isAdvanced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Coyne isAdvanced. Learn about Hemoglobin E Disease.
- Hemoglobin SC DiseaseDr. Coyne isAdvanced. Learn about Hemoglobin SC Disease.
- HemoglobinopathyDr. Coyne isAdvanced. Learn about Hemoglobinopathy.
- Sickle Cell DiseaseDr. Coyne isAdvanced. Learn about Sickle Cell Disease.
- Experienced
- AnemiaDr. Coyne isExperienced. Learn about Anemia.
- Autism Spectrum DisorderDr. Coyne isExperienced. Learn about Autism Spectrum Disorder.
- Chronic Graft Versus Host Disease (cGvHD)
- Congenital Hemolytic AnemiaDr. Coyne isExperienced. Learn about Congenital Hemolytic Anemia.
- Ehlers-Danlos Syndrome (EDS)Dr. Coyne isExperienced. Learn about Ehlers-Danlos Syndrome (EDS).
- Graft Versus Host Disease (GvHD)Dr. Coyne isExperienced. Learn about Graft Versus Host Disease (GvHD).